170 related articles for article (PubMed ID: 10728907)
1. Brain derived neurotrophic factor protects human neuroblastoma cells from DNA damaging agents.
Middlemas DS; Kihl BK; Moody NM
J Neurooncol; 1999; 45(1):27-36. PubMed ID: 10728907
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
Jaboin J; Kim CJ; Kaplan DR; Thiele CJ
Cancer Res; 2002 Nov; 62(22):6756-63. PubMed ID: 12438277
[TBL] [Abstract][Full Text] [Related]
3. Brain-derived neurotrophic factor promotes survival and chemoprotection of human neuroblastoma cells.
Middlemas DS; Kihl BK; Zhou J; Zhu X
J Biol Chem; 1999 Jun; 274(23):16451-60. PubMed ID: 10347207
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death.
Li Z; Zhang J; Liu Z; Woo CW; Thiele CJ
Cell Death Differ; 2007 Feb; 14(2):318-26. PubMed ID: 16778834
[TBL] [Abstract][Full Text] [Related]
5. [Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].
Li AM; Zhang JH; Zhang JH; Zhang KR; Rong DJ
Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):535-9. PubMed ID: 17044982
[TBL] [Abstract][Full Text] [Related]
6. P53/PUMA are potential targets that mediate the protection of brain-derived neurotrophic factor (BDNF)/TrkB from etoposide-induced cell death in neuroblastoma (NB).
Hua Z; Zhan Y; Zhang S; Dong Y; Jiang M; Tan F; Liu Z; Thiele CJ; Li Z
Apoptosis; 2018 Aug; 23(7-8):408-419. PubMed ID: 29959561
[TBL] [Abstract][Full Text] [Related]
7. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.
Matsumoto K; Wada RK; Yamashiro JM; Kaplan DR; Thiele CJ
Cancer Res; 1995 Apr; 55(8):1798-806. PubMed ID: 7712490
[TBL] [Abstract][Full Text] [Related]
8. Resistance to chemotherapy mediated by TrkB in neuroblastomas.
Ho R; Eggert A; Hishiki T; Minturn JE; Ikegaki N; Foster P; Camoratto AM; Evans AE; Brodeur GM
Cancer Res; 2002 Nov; 62(22):6462-6. PubMed ID: 12438236
[TBL] [Abstract][Full Text] [Related]
9. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
Cernaianu G; Brandmaier P; Scholz G; Ackermann OP; Alt R; Rothe K; Cross M; Witzigmann H; Tröbs RB
J Pediatr Surg; 2008 Jul; 43(7):1284-94. PubMed ID: 18639684
[TBL] [Abstract][Full Text] [Related]
10. Trk inhibitor attenuates the BDNF/TrkB-induced protection of neuroblastoma cells from etoposide in vitro and in vivo.
Li Z; Zhang Y; Tong Y; Tong J; Thiele CJ
Cancer Biol Ther; 2015; 16(3):477-83. PubMed ID: 25700942
[TBL] [Abstract][Full Text] [Related]
11. Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity.
Scala S; Wosikowski K; Giannakakou P; Valle P; Biedler JL; Spengler BA; Lucarelli E; Bates SE; Thiele CJ
Cancer Res; 1996 Aug; 56(16):3737-42. PubMed ID: 8706017
[TBL] [Abstract][Full Text] [Related]
12. Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death.
Li Z; Jaboin J; Dennis PA; Thiele CJ
Cancer Res; 2005 Mar; 65(6):2070-5. PubMed ID: 15781614
[TBL] [Abstract][Full Text] [Related]
13. [Blocking TrkB-BDNF signal pathway decreases the livability of neuroblastoma cells].
Zhang JH; Li AM; Chen S; Tong HX; Zhang KR; Zhang JH
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):47-50. PubMed ID: 18289471
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.
Czarnecka M; Trinh E; Lu C; Kuan-Celarier A; Galli S; Hong SH; Tilan JU; Talisman N; Izycka-Swieszewska E; Tsuei J; Yang C; Martin S; Horton M; Christian D; Everhart L; Maheswaran I; Kitlinska J
Oncogene; 2015 Jun; 34(24):3131-43. PubMed ID: 25132261
[TBL] [Abstract][Full Text] [Related]
15. Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization.
Bedrnicek J; Vicha A; Jarosova M; Holzerova M; Cinatl J; Michaelis M; Cinatl J; Eckschlager T
Neoplasma; 2005; 52(5):415-9. PubMed ID: 16151587
[TBL] [Abstract][Full Text] [Related]
16. BDNF dependence in neuroblastoma.
Feng X; Jiang H; Baik JC; Edgar C; Eide FF
J Neurosci Res; 2001 May; 64(4):355-63. PubMed ID: 11340642
[TBL] [Abstract][Full Text] [Related]
17. Astrocyte truncated tropomyosin receptor kinase B mediates brain-derived neurotrophic factor anti-apoptotic effect leading to neuroprotection.
Saba J; Turati J; Ramírez D; Carniglia L; Durand D; Lasaga M; Caruso C
J Neurochem; 2018 Sep; 146(6):686-702. PubMed ID: 29851427
[TBL] [Abstract][Full Text] [Related]
18. Type I interferons impair BDNF-induced cell signaling and neurotrophic activity in differentiated human SH-SY5Y neuroblastoma cells and mouse primary cortical neurons.
Dedoni S; Olianas MC; Ingianni A; Onali P
J Neurochem; 2012 Jul; 122(1):58-71. PubMed ID: 22533963
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells.
Nakamura K; Martin KC; Jackson JK; Beppu K; Woo CW; Thiele CJ
Cancer Res; 2006 Apr; 66(8):4249-55. PubMed ID: 16618748
[TBL] [Abstract][Full Text] [Related]
20. The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan.
Zage PE; Graham TC; Zeng L; Fang W; Pien C; Thress K; Omer C; Brown JL; Zweidler-McKay PA
Cancer; 2011 Mar; 117(6):1321-91. PubMed ID: 20960503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
